Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy

Table 2 Relationship between the death within 3 years and inflammation and nutrition-related indicators of 181 advanced gastric cancer patients

Patients’ characteristics	No death (n = 97)	Death (n = 84)	χ2 value	P value
Hemoglobin (g/L)			14.660	< 0.001
< 119	37	56
≥ 119	60	28
Albumin (g/L)			16.099	< 0.001
< 34.38	19	40
≥ 34.38	78	44
Neutrophil count (× 109/L)			13.977	< 0.001
< 5.2	83	59
≥ 5.2	8	25
Lymphocyte count (× 109/L)			5.177	0.023
< 1.42	27	37
≥ 1.42	70	47
Monocyte count (× 109/L)			5.389	0.020
> 0.43	65	42
≤ 0.43	32	42
Platelet count (× 109/L)			0.305	0.581
< 324	13	9
≥ 324	84	75
NLR			14.625	< 0.001
< 3.11	82	50
≥ 3.11	15	34
PLR
< 159.3	55	29	8.902	0.003
≥ 159.3	42	55
LMR			5.288	0.021
< 3.34	30	40
≥ 3.34	67	44
SII			19.731	< 0.001
< 801.43	56	21
≥ 801.43	41	63
PNI			17.113	< 0.001
< 43.42	23	45
≥ 43.42	74	39
PAR			21.146	< 0.001
< 9.09	84	47
≥ 9.09	13	37
AGR			5.070	0.024
< 1.12	10	19
≥ 1.12	87	65
Globulin (g/L)			0.009	0.926
< 30.02	34	30
≥ 30.02	63	54

NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio; LMR: Lymphocyte-monocyte ratio; SII: Systemic immune inflammation index; PNI: Prognostic nutritional index; AGR: Albumin to globulin ratio; PAR: Platelet-albumin ratio.